☰
✕

Thrombectomy devices market

Thrombectomy Devices Market, By Product Type (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices), By Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Superficial Vein Thrombosis, Renal Vein Thrombosis (RVT), Arterial Thrombosis (Atherothrombosis), Others (Ischemic Stroke, etc.)), By End User (Hospitals, Ambulatory Surgical Centers, Others (Academic and Research Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Request Free Sample
  • Sep 2023
  • CMI2254
  • 180 Pages
  • Excel & Pdf
  • Medical Devices

Global thrombectomy devices market is estimated to be valued at US$ 1.68 Bn in 2023, and is expected to exhibit a CAGR of 7.5% during the forecast period (2023-2030).

Analysts’ Views on Global Thrombectomy Devices Market:

Thrombectomy devices are used in thrombectomy process. Mechanical thrombectomy devices comprise of a wide array of endovascular tools taht removes thrombi from the neurovasculature in acute ischemic stroke patients. Rising number of patient population with a deep vein thrombosis, pulmonary embolism, and renal vein thrombosis are expected to increase the number of thrombectomy procedures. Thus, it offers the opportunity to various manufacturers to offer various thrombectomy devices such as mechanical thrombectomy and aspiration thrombectomy devices that allows surgeons to perform such surgeries more efficiently.

Figure 1. Global Thrombectomy Devices Market Share (%), By Product Type, 2023

Global Thrombectomy Devices Market– Drivers

  • Increasing product approval by regulatory authorities: Increasing product approval by regulatory authorities such as China’s National Medical Product Administration is expected to drive the global thrombectomy devices market growth over the forecast period. For instance, on August 31, 2023, Rapid Medical, a Israel-based developer of neurovascular devices, announced that its Tigertriever revascularization device had received approval from China’s National Medical Product Administration.  Tigertriever provides patient-specific solutions for removing blood clots from the brain in the treatment of ischemic stroke.Moreover, Increasing product approvals by regulatory authority such as U.S. Food and Drug Administration is also expected to boost the global thrombectomy devices market in North America region . For instance, on June 14, 2023, Surmodics Inc., announced that the U.S. Food and Drug Administration had received approval for Pounce LP Thrombectomy System that is  intended for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature in vessels 3.5 mm to 6 mm in diameter. The Pounce LP Thrombectomy System, a new addition to the Pounce platform, is indicated for use  in vessels, ranging from 2 mm to 4 mm in diameter, sizes typical of vessels found below the knee.

Figure 2. Global Thrombectomy Devices Market Share(%), By Region, 2023

Global Thrombectomy Devices Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global thrombectomy devices market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2023. North America thrombectomy devices market is expected to witness significant growth in the near future due to high prevalence of pulmonary embolism in the region. Increasing prevalence of pulmonary embolism among the patients is expected to drive the North America thrombectomy devices market growth over the forecast period. For instance, according to the data published in The Journal of the American Medical Association, in January 2021, a cross-sectional study was conducted in 7 U.S.-based hospitals among 740 patients  that stated that pulmonary embolism was detected in 5.9% of patients by using a predefined diagnostic algorithm.

Global Thrombectomy Devices Market – Impact of Coronavirus (COVID-19) Pandemic

Since, the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of things from one place to another.

However, the COVID-19 pandemic had negative impact on the global thrombectomy devices market as supply of key materials such as probes required for interventional ablation have been severely disrupted due to forced quarantine, and imposed lockdowns in various countries thatled to disruption in the link between warehouses. This shortage of thrombectomy devices and components used in the thrombectomy procedures had affected the supply chain of the global thrombectomy devices market. The COVID-19 pandemic caused major disruptions to clinical trial execution in the U.S., impacting key stakeholders across the medical devices industry. According to the data published by Medrio, global software company, in May 2020, an estimated 80% of non-COVID-19 trials were stopped or interrupted as a result of the COVID-19 pandemic.

Thrombectomy Devices Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 1.68 Bn
Historical Data for: 2018 to 2022 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 7.5% 2030 Value Projection: US$ 2.78 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices
  • By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Superficial Vein Thrombosis, Renal Vein Thrombosis (RVT), Arterial Thrombosis (Atherothrombosis), Others (Ischemic Stroke, etc.)
  • By End User: Hospitals, Ambulatory Surgical Centers, Others (Academic and Research Institutes, etc.)
Companies covered:

Boston Scientific Corporation, Medtronic, Merit Medical System Inc., Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Vetex Medical Ltd., Edwards Lifesciences Corporation, Penumbra Inc., Control Medical Technology, LLC., Rapid Medical, Abbott and Surmodics, Inc.
Growth Drivers:
  • Increasing product approval by regulatory authorities
  • Increasing launch of awareness campaign for deep vein thrombosis
Restraints & Challenges:
  • Increasing product recall by regulatory authorities

Global Thrombectomy Devices Market- Segmentation

Global thrombectomy devices market  is segmented into product type, application, end user, and region.

  • Based on product type, the market is segmented into mechanical thrombectomy devices, aspiration thrombectomy devices, hydrodynamic thrombectomy devices, and ultrasonic thrombectomy devices. Out of which, the mechanical thrombectomy devices segment is expected to hold a dominant position in the global thrombectomy devices market during the forecast period due to increasing product launches by key market players.
  • Based on application, the market is segmented into deep vein thrombosis (DVT), pulmonary embolism (PE), superficial vein thrombosis, reneal vein thrombosis (RVT), arterial thrombosis (Atherothrombosis), and Others (Ischemic Stroke, etc.). Out of which, deep vein thrombosis (VBT) segment  is expected to dominate the market over the forecast period due  to increasing prevalence of deep vein thrombosis.
  • Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and Others (Academic and Research Institutes, etc.). Out of which, the hospitals segment is expected to dominate the market over the forecast period due to increasing number of hospitals for thrombectomy process.
  • Among all the segmentation, the application segment is expected to dominate the market over the forecast period due to increasing prevalence of deep vein thrombosis and pulmonary embolism

Global Thrombectomy Devices Market- Cross Sectional Analysis

Among application segment deep vein thrombosis is expected to drive the global thrombectomy devices market over the forecast period due to increasing adoption of inorganic strategies such as launch of campaigns, in order to raise awareness about deep vein thrombosis. For instance, in November 2020, The Bristol Myers Squibb, biopharmaceutical company and Pfizer Inc., pharmaceutical company, Alliance, announced the launch of ‘No Time to Wait’ awareness campaign, to raise awareness about symptoms of deep vein thrombosis. This campaign helps people to find additional information about deep vein thrombosis. 

Global Thrombectomy Devices Market : Key Developments

In April 2022,  Cordis, a medical device company, announced a strategic investment venture with Endovascular Engineering (E2), a developer of next-generation thrombectomy devices, to treat patients with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). The venture will helps to accelerate the development of thrombectomy devices.

Global Thrombectomy Devices Market: Key Trends

  • Increasing acquisition by key market players: Increasing acquisition among key market players. For instance, in September 2021, Boston Scientific Corporation, a global medical device company, announced the acquisition of Devoro Medical, Inc., a developer of the WOLF Thrombectomy Platform. The acquisition included mechanical thrombectomy platform to peripheral interventions portfolio and helps to expand Boston Scientific Corporation thrombectomy devices product portfolio.

Global Thrombectomy Devices Market: Restraint

  • Increasing product recall by regulatory authorities: Increasing product recall by regulatory authorities such as U.S. Food and Drug Administration is expected to hinder the market growth over the forecast period. For instance, in February 2022, the U.S. Food and Drug Administration recalled Arrow-Trerotola Percutaneous Thrombolytic Device, manufactured by Arrow-International, LLC a subsidiary of Teleflex Incorporated. The device was recalled due to risk of tip damage during use that canresult in tip detachment from the basket. This could potentially lead to vascular injuries including obstruction (blockage) of the vessel, additional thrombosis (blood clot), ischemia (inadequate blood supply), infarction (heart attack), infection or death.
  • Counterbalance: Recall means when a firm removes or corrects a marketed product that the Food and Drug Administration considers to be in violation of the laws, that it administers and against  which the agency would initiate legal action. The customers need to be first informed about the recall procedure and safety of the customers must be ensured at first, so that any damage can be prevented regarding the perception of the brand and the business.

Key players focusing on developing advancing products with safety and cost effective, and this is expected to drive the market growth over the forecast period.

Global Thrombectomy Devices Market - Key Players

Major players operating in the global thrombectomy devices market include include Boston Scientific Corporation, Medtronic, Merit Medical System Inc., Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Vetex Medical Ltd., Edwards Lifesciences Corporation, Penumbra Inc., Control Medical Technology, LLC., Rapid Medical, Abbott and Surmodics, Inc.

*Definition: Thrombectomy involves removing a clot from a blood vessel, most commonly from the brain, heart, or lungs. Stroke and myocardial infarction are two of the leading causes of death worldwide, and are increasingly treated through techniques that include intravascular thrombolytics, mechanical thrombectomy, or a combination of both

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Approvals/Launches
    • Mergers, Acquisitions, and Collaborations
    • Regulatory Scenario
    • Pricing Analysis
    • Key Developments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Thrombectomy Devices Market – COVID-19 Impact Analysis
    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand
  5. Global Thrombectomy Devices Market, By Product Type, 2018– 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018–2030
      • Segment Trends
    • Mechanical Thrombectomy Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Aspiration Thrombectomy Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Hydrodynamic Thrombectomy Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Ultrasonic Thrombectomy Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
  6. Global Thrombectomy Devices Market, By Application, 2018 – 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018–2030
      • Segment Trends
    • Deep Vein Thrombosis (DVT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Pulmonary Embolism (PE)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Superficial Vein Thrombosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Renal Vein Thrombosis (RVT)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Arterial Thrombosis (Atherothrombosis)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Others (Ischemic Stroke, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
  7. Global Thrombectomy Devices Market, By End User, 2018 – 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018–2030
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
    • Others (Academic and Research Institutes, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  8. Global Thrombectomy Devices Market, By Region, 2018 – 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018–2030
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018–2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country,  2018 –2030, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018–2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country,  2018 –2030, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth. By Product Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018–2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country,  2018 –2030, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth. By End User, 2018–2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country,  2018 –2030, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth By Product Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth By Application, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth By End User, 2018–2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth By Country,  2018 –2030, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018–2030, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region,  2018 –2030, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Medtronic
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Merit Medical System Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Stryker Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Terumo Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Teleflex Incorporated
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Vetex Medical Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Edwards Lifesciences Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Penumbra Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Control Medical Technology, LLC.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Rapid Medical
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Surmodics Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Analysts’ Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 37 market data tables and 35 figures on “Global Thrombectomy Devices Market” – Global forecast to 2030

Global Thrombectomy Devices Market Detailed Segmentation:

  • By Product Type:
    • Mechanical Thrombectomy Devices
    • Aspiration Thrombectomy Devices
    • Hydrodynamic Thrombectomy Devices
    • Ultrasonic Thrombectomy Devices
  • By Application:
    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism (PE)
    • Superficial Vein Thrombosis
    • Renal Vein Thrombosis (RVT)
    • Arterial Thrombosis (Atherothrombosis)
    • Others (Ischemic Stroke, etc.)
  • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Others (Academic and Research Institutes, etc)
  • By Region:
    • North America
      • By Product Type:
        • Mechanical Thrombectomy Devices
        • Aspiration Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
        • Ultrasonic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Others (Ischemic Stroke, etc.)
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Others (Academic and Research Institutes, etc.)
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Mechanical Thrombectomy Devices
        • Aspiration Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
        • Ultrasonic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Others (Ischemic Stroke, etc.)
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Others (Academic and Research Institutes, etc.)
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Mechanical Thrombectomy Devices
        • Aspiration Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
        • Ultrasonic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Others (Ischemic Stroke, etc.)
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Others (Academic and Research Institutes, etc.)
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Mechanical Thrombectomy Devices
        • Aspiration Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
        • Ultrasonic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Others (Ischemic Stroke, etc.)
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Others (Academic and Research Institutes, etc.)
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Mechanical Thrombectomy Devices
        • Aspiration Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
        • Ultrasonic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Others (Ischemic Stroke, etc.)
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Others (Academic and Research Institutes, etc.)
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Mechanical Thrombectomy Devices
        • Aspiration Thrombectomy Devices
        • Hydrodynamic Thrombectomy Devices
        • Ultrasonic Thrombectomy Devices
      • By Application
        • Deep Vein Thrombosis (DVT)
        • Pulmonary Embolism (PE)
        • Superficial Vein Thrombosis
        • Renal Vein Thrombosis (RVT)
        • Arterial Thrombosis (Atherothrombosis)
        • Others (Ischemic Stroke, etc.)
      • By End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Others (Academic and Research Institutes, etc.)
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global thrombectomy devices market during the forecast period (2023-2030)?

Global thrombectomy devices market is estimated to be valued at US$ 1.68 Bn in 2023, and is expected to exhibit a CAGR of 7.5% between 2023 and 2030.

What are the major factors driving the market growth?

Increasing product approval by regularity authorities and increasing launch of awareness campaign for deep vein thrombosis are expected to drive the market growth.

Which is the leading product type segment in the market?

Mechanical thrombectomy devices is the leading product type segment in the market.

What are the key factors hampering the growth of the market?

Increasing product recall by regulatory authority is expected to hinder the market growth over the forecast period.

Which are the major players operating in the market?

Major players operating in the market are include Boston Scientific Corporation, Medtronic, Merit Medical System Inc., Stryker Corporation, Terumo Corporation, Teleflex Incorporated, Vetex Medical Ltd., Edwards Lifesciences Corporation, Penumbra Inc., Control Medical Technology, LLC., Rapid Medical, Abbott and Surmodics, Inc.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Buy Now with Special Discount
Customize Now